Normative data for the Slovak version of the Frontal Assessment Battery (FAB)

Abrahámová, Miroslava; Smolejova, Eva; Dančík, Daniel; Pribišová, Karin; Heretik, Anton

doi:10.1080/23279095.2020.1748031

Cited by 5 publications

(1 citation statement)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The choice of this FAB version stems from its robust psychometric architecture that boasts a solid factorial structure, good internal consistency, excellent interrater and test-retest reliabilities, and regression-based norms extracted –to the best of our knowledge– from the largest normative sample ever recruited in Italy for a neuropsychological tool ( Ilardi et al, 2022b ). In addition, the FAB15 solves the well-known problem concerning the pronounced ceiling effect typically encountered in both healthy ( Asaadi et al, 2016 ; Bezdicek et al, 2017 ; Hurtado-Pomares et al, 2018b ; Goh et al, 2019 ; Abrahámová et al, 2022 ) and clinical populations ( Stamelou et al, 2015 ; Hurtado-Pomares et al, 2018b ; Goh et al, 2019 ) on the sixth and last FAB subtest, which was originally devised to explore one the components of the environmental dependency, i.e., the prehension behavior ( Dubois et al, 2000 ). This makes the FAB15 more valid and severe as compared with the conventional six-item battery.…”

Section: Introductionmentioning

confidence: 99%

The assessment of executive functions to test the integrity of the nigrostriatal network: A pilot study

Ilardi¹,

Maio

Villano

et al. 2023

Front. Psychol.

View full text Add to dashboard Cite

BackgroundParkinson’s disease (PD) is a chronic neurodegenerative disorder characterized by motor and non-motor symptoms. The latter mainly include affective, sleep, and cognitive deficits. Non-demented PD patients often demonstrate impairments in several executive domains following neuropsychological evaluation. The current pilot study aims at assessing the discriminatory power of the Frontal Assessment Battery-15 (FAB15) in differentiating (i) non-demented PD patients and healthy controls and (ii) PD patients with more and less pronounced motor symptoms.MethodsThirty-nine non-demented early-stage PD patients in the “on” dopamine state (26 females, mean age = 64.51 years, SD = 6.47, mean disease duration = 5.49 years, SD = 2.28) and 39 healthy participants (24 females, mean age = 62.60 years, SD = 5.51) were included in the study. All participants completed the FAB15. Motor symptoms of PD patients were quantified via the Unified Parkinson’s Disease Rating Scale-Part III (UPDRS-Part III) and Hoehn and Yahr staging scale (H&Y).ResultsThe FAB15 score, adjusted according to normative data for sex, age, and education, proved to be sufficiently able to discriminate PD patients from healthy controls (AUC = 0.69 [95% CI 0.60–0.75], SE = 0.06, p = 0.04, optimal cutoff = 11.29). Conversely, the battery lacked sufficient discriminative capability to differentiate PD patients based on the severity of motor symptoms.ConclusionThe FAB15 may be a valid tool for distinguishing PD patients from healthy controls. However, it might be less sensitive in identifying clinical phenotypes characterized by visuospatial impairments resulting from posteroparietal and/or temporal dysfunctions. In line with previous evidence, the battery demonstrated to be not expendable in the clinical practice for monitoring the severity of PD-related motor symptoms.

show abstract